Ignite Creation Date:
2024-05-06 @ 12:17 PM
Last Modification Date:
2024-10-26 @ 12:57 PM
Study NCT ID:
NCT03727126
Status:
UNKNOWN
Last Update Posted:
2020-10-14
First Post:
2018-10-27
Brief Title:
Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer
Sponsor:
GEM Hospital Research Center
Organization:
GEM Hospital Research Center
Study Overview
Official Title:
Robotic Versus Thoracolaparoscopic Esophagectomy for Carcinoma Esophagus a Prospective Comparative Study
Status:
UNKNOWN
Status Verified Date:
2020-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Esophageal cancer is a debilitating condition The treatment involved is complex requiring a combination of chemotherapy and surgery in most cases Complete removal of the tumor and the adjacent lymph nodes is of utmost importance in improving the survival Lymph node yield following surgery helps in proper staging of the disease and is an important prognosticating variable It is hypothesized that the lymph node yield following robotic esophagectomy is higher than that following thoracolaparoscopic esophagectomy The study aims to compare the short term oncological outcomes following robotic esophagectomy and thoracolaparoscopic esophagectomy for carcinoma esophagus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None